Checked against the current FDA label, named clinical trials, and the sources listed on this site.
01Milk excretion after Motilium 10 mg
Domperidone is excreted in human breast milk after oral Motilium 10 mg. Breast-fed infants receive less than 0.1% of the maternal weight-adjusted dose. Cardiac effects in the infant cannot be excluded. The decision is whether to discontinue breast-feeding or to discontinue Motilium. A 10 mg tablet is one labelled strength on that carton.
Sources and how this letter was sealed
EMA / Motilium SmPC: QT, 30 mg/day, age >60, CYP3A4; milk <0.1% maternal dose.
FDA: domperidone not approved for human use; lactation warnings.
Method in brief: open primary sources, annotate against the current FDA label,
countersign by Dr. Nora Lindqvist, MD, then seal with a dated review.
Full walk-through on the method page and
editorial standards.
How to cite this page - Vancouver style
Juvia Pharma Drug Reference. QT limits and why milk supply stays off-label [Internet]. Stockholm: Juvia Pharma; 21 October 2026 [cited 2026 Aug 21]. Available from: https://juviapharma.com/postscripts/motilium-qt-milk/
Desk thread
Answers follow the EMA / MHRA Motilium 10 mg SmPC.
Domperidone is excreted in human breast milk after oral Motilium 10 mg. Breast-fed infants receive less than 0.1% of the maternal weight-adjusted dose. Cardiac effects in the infant cannot be excluded. The decision is whether to discontinue breast-feeding or to discontinue Motilium. A 10 mg tablet is one labelled strength on that carton.
Before you start, stop, or change any medicine mentioned above, run it past your prescriber or pharmacist - they hold your chart, this despatch does not. Desk notice.